Medical Care
Global LFA-based Cardiac Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 341242
- Pages: 131
- Figures: 139
- Views: 1
In 2024, the global market size of LFA-based Cardiac was estimated to be worth US$ 4181 million and is forecast to reach approximately US$ 7067 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The industry"s leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.
The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of LFA-based Cardiac in global and regional level.
Chapter 3: Detailed analysis of LFA-based Cardiac company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, LFA-based Cardiac revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The industry"s leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.
The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of LFA-based Cardiac in global and regional level.
Chapter 3: Detailed analysis of LFA-based Cardiac company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, LFA-based Cardiac revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 LFA-based Cardiac Product Introduction
1.2 Market by Type
1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Troponin I
1.2.3 Troponin T
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global LFA-based Cardiac Market Size Estimates and Forecasts
2.2 LFA-based Cardiac Market Size by Region: 2024 Versus 2031
2.2.1 Global LFA-based Cardiac Revenue by Region: 2020-2025
2.2.2 Global LFA-based Cardiac Revenue Forecast by Region (2026-2031)
2.2.3 Global LFA-based Cardiac Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global LFA-based Cardiac Revenue by Type (2020-2031)
3.1.2 Global LFA-based Cardiac Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global LFA-based Cardiac Revenue by Application (2020-2031)
3.2.2 Global LFA-based Cardiac Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Troponin I of LFA-based Cardiac Revenue Market Share by Application
3.3.2 Troponin T of LFA-based Cardiac Revenue Market Share by Application
3.3.3 CK-MB of LFA-based Cardiac Revenue Market Share by Application
3.3.4 Myoglobin of LFA-based Cardiac Revenue Market Share by Application
3.3.5 Others of LFA-based Cardiac Revenue Market Share by Application
4 Global LFA-based Cardiac by Company
4.1 Global LFA-based Cardiac Revenue by Company (2020-2025)
4.2 Global LFA-based Cardiac Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key LFA-based Cardiac Companies around the World: Ranking by Revenue
4.3.2 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global LFA-based Cardiac Companies Headquarters & Product Type
4.4.1 Global LFA-based Cardiac Companies Headquarters
4.4.2 Date of International Companies Enter into LFA-based Cardiac Market
4.4.3 Global LFA-based Cardiac Companies Product & Service
4.4.4 Troponin I Revenue Market Share of LFA-based Cardiac by Company
4.4.5 Troponin T Revenue Market Share of LFA-based Cardiac by Company
4.4.6 CK-MB Revenue Market Share of LFA-based Cardiac by Company
4.4.7 Myoglobin Revenue Market Share of LFA-based Cardiac by Company
4.4.8 Others Revenue Market Share of LFA-based Cardiac by Company
4.5 Global LFA-based Cardiac Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche LFA-based Cardiac Products Offered
5.1.4 Roche LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.1.5 Roche LFA-based Cardiac Revenue by Product in 2024
5.1.6 Roche LFA-based Cardiac Revenue by Application in 2024
5.1.7 Roche LFA-based Cardiac Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Corporation Information
5.2.2 Abbott Description, Business Overview
5.2.3 Abbott LFA-based Cardiac Products Offered
5.2.4 Abbott LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.2.5 Abbott LFA-based Cardiac Revenue by Product in 2024
5.2.6 Abbott LFA-based Cardiac Revenue by Application in 2024
5.2.7 Abbott LFA-based Cardiac Revenue by Geographic Area in 2024
5.2.8 Abbott Recent Developments
5.3 Siemens
5.3.1 Siemens Corporation Information
5.3.2 Siemens Description, Business Overview
5.3.3 Siemens LFA-based Cardiac Products Offered
5.3.4 Siemens LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.3.5 Siemens LFA-based Cardiac Revenue by Product in 2024
5.3.6 Siemens LFA-based Cardiac Revenue by Application in 2024
5.3.7 Siemens LFA-based Cardiac Revenue by Geographic Area in 2024
5.3.8 Siemens Recent Developments
5.4 Danaher
5.4.1 Danaher Corporation Information
5.4.2 Danaher Description, Business Overview
5.4.3 Danaher LFA-based Cardiac Products Offered
5.4.4 Danaher LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.4.5 Danaher LFA-based Cardiac Revenue by Product in 2024
5.4.6 Danaher LFA-based Cardiac Revenue by Application in 2024
5.4.7 Danaher LFA-based Cardiac Revenue by Geographic Area in 2024
5.4.8 Danaher Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Corporation Information
5.5.2 Bio-Rad Laboratories Description, Business Overview
5.5.3 Bio-Rad Laboratories LFA-based Cardiac Products Offered
5.5.4 Bio-Rad Laboratories LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.5.5 Bio-Rad Laboratories LFA-based Cardiac Revenue by Product in 2024
5.5.6 Bio-Rad Laboratories LFA-based Cardiac Revenue by Application in 2024
5.5.7 Bio-Rad Laboratories LFA-based Cardiac Revenue by Geographic Area in 2024
5.5.8 Bio-Rad Laboratories Recent Developments
5.6 BioMérieux
5.6.1 BioMérieux Corporation Information
5.6.2 BioMérieux Description, Business Overview
5.6.3 BioMérieux LFA-based Cardiac Products Offered
5.6.4 BioMérieux LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.6.5 BioMérieux LFA-based Cardiac Revenue by Product in 2024
5.6.6 BioMérieux LFA-based Cardiac Revenue by Application in 2024
5.6.7 BioMérieux LFA-based Cardiac Revenue by Geographic Area in 2024
5.6.8 BioMérieux Recent Developments
5.7 Thermo Fisher
5.7.1 Thermo Fisher Corporation Information
5.7.2 Thermo Fisher Description, Business Overview
5.7.3 Thermo Fisher LFA-based Cardiac Products Offered
5.7.4 Thermo Fisher LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.7.5 Thermo Fisher LFA-based Cardiac Revenue by Product in 2024
5.7.6 Thermo Fisher LFA-based Cardiac Revenue by Application in 2024
5.7.7 Thermo Fisher LFA-based Cardiac Revenue by Geographic Area in 2024
5.7.8 Thermo Fisher Recent Developments
5.8 Ortho Clinical Diagnostics
5.8.1 Ortho Clinical Diagnostics Corporation Information
5.8.2 Ortho Clinical Diagnostics Description, Business Overview
5.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Products Offered
5.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.8.5 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Product in 2024
5.8.6 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Application in 2024
5.8.7 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Geographic Area in 2024
5.8.8 Ortho Clinical Diagnostics Recent Developments
5.9 LSI Medience Corporation
5.9.1 LSI Medience Corporation Corporation Information
5.9.2 LSI Medience Corporation Description, Business Overview
5.9.3 LSI Medience Corporation LFA-based Cardiac Products Offered
5.9.4 LSI Medience Corporation LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.9.5 LSI Medience Corporation LFA-based Cardiac Revenue by Product in 2024
5.9.6 LSI Medience Corporation LFA-based Cardiac Revenue by Application in 2024
5.9.7 LSI Medience Corporation LFA-based Cardiac Revenue by Geographic Area in 2024
5.9.8 LSI Medience Corporation Recent Developments
5.10 Randox laboratories
5.10.1 Randox laboratories Corporation Information
5.10.2 Randox laboratories Description, Business Overview
5.10.3 Randox laboratories LFA-based Cardiac Products Offered
5.10.4 Randox laboratories LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.10.5 Randox laboratories LFA-based Cardiac Revenue by Product in 2024
5.10.6 Randox laboratories LFA-based Cardiac Revenue by Application in 2024
5.10.7 Randox laboratories LFA-based Cardiac Revenue by Geographic Area in 2024
5.10.8 Randox laboratories Recent Developments
5.11 Wondfo Biotech
5.11.1 Wondfo Biotech Corporation Information
5.11.2 Wondfo Biotech Description, Business Overview
5.11.3 Wondfo Biotech LFA-based Cardiac Products Offered
5.11.4 Wondfo Biotech LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.11.5 Wondfo Biotech LFA-based Cardiac Revenue by Product in 2024
5.11.6 Wondfo Biotech LFA-based Cardiac Revenue by Application in 2024
5.11.7 Wondfo Biotech LFA-based Cardiac Revenue by Geographic Area in 2024
5.11.8 Wondfo Biotech Recent Developments
6 North America
6.1 North America LFA-based Cardiac Market Size YoY Growth 2020-2031
6.2 North America LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
6.3 North America LFA-based Cardiac Revenue by Type (2020-2025)
6.4 North America LFA-based Cardiac Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific LFA-based Cardiac Market Size YoY Growth 2020-2031
7.2 Asia-Pacific LFA-based Cardiac Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific LFA-based Cardiac Revenue by Type (2020-2025)
7.4 Asia-Pacific LFA-based Cardiac Revenue by Application (2020-2025)
8 Europe
8.1 Europe LFA-based Cardiac Market Size YoY Growth 2020-2031
8.2 Europe LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
8.3 Europe LFA-based Cardiac Revenue by Type (2020-2025)
8.4 Europe LFA-based Cardiac Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America LFA-based Cardiac Market Size YoY Growth 2020-2031
9.2 Latin America LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
9.3 Latin America LFA-based Cardiac Revenue by Type (2020-2025)
9.4 Latin America LFA-based Cardiac Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America LFA-based Cardiac Market Size YoY Growth 2020-2031
10.2 Middle East and Africa LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa LFA-based Cardiac Revenue by Type (2020-2025)
10.4 Middle East and Africa LFA-based Cardiac Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 LFA-based Cardiac Supply Chain Analysis
11.2 LFA-based Cardiac Key Raw Materials and Upstream Suppliers
11.3 LFA-based Cardiac Clients Analysis
11.4 LFA-based Cardiac Sales Channel and Sales Model Analysis
11.4.1 LFA-based Cardiac Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 LFA-based Cardiac Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 LFA-based Cardiac Distributors
12 LFA-based Cardiac Market Dynamics
12.1 LFA-based Cardiac Industry Trends
12.2 LFA-based Cardiac Market Drivers
12.3 LFA-based Cardiac Market Challenges
12.4 LFA-based Cardiac Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 LFA-based Cardiac Product Introduction
1.2 Market by Type
1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Troponin I
1.2.3 Troponin T
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global LFA-based Cardiac Market Size Estimates and Forecasts
2.2 LFA-based Cardiac Market Size by Region: 2024 Versus 2031
2.2.1 Global LFA-based Cardiac Revenue by Region: 2020-2025
2.2.2 Global LFA-based Cardiac Revenue Forecast by Region (2026-2031)
2.2.3 Global LFA-based Cardiac Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global LFA-based Cardiac Revenue by Type (2020-2031)
3.1.2 Global LFA-based Cardiac Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global LFA-based Cardiac Revenue by Application (2020-2031)
3.2.2 Global LFA-based Cardiac Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Troponin I of LFA-based Cardiac Revenue Market Share by Application
3.3.2 Troponin T of LFA-based Cardiac Revenue Market Share by Application
3.3.3 CK-MB of LFA-based Cardiac Revenue Market Share by Application
3.3.4 Myoglobin of LFA-based Cardiac Revenue Market Share by Application
3.3.5 Others of LFA-based Cardiac Revenue Market Share by Application
4 Global LFA-based Cardiac by Company
4.1 Global LFA-based Cardiac Revenue by Company (2020-2025)
4.2 Global LFA-based Cardiac Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key LFA-based Cardiac Companies around the World: Ranking by Revenue
4.3.2 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global LFA-based Cardiac Companies Headquarters & Product Type
4.4.1 Global LFA-based Cardiac Companies Headquarters
4.4.2 Date of International Companies Enter into LFA-based Cardiac Market
4.4.3 Global LFA-based Cardiac Companies Product & Service
4.4.4 Troponin I Revenue Market Share of LFA-based Cardiac by Company
4.4.5 Troponin T Revenue Market Share of LFA-based Cardiac by Company
4.4.6 CK-MB Revenue Market Share of LFA-based Cardiac by Company
4.4.7 Myoglobin Revenue Market Share of LFA-based Cardiac by Company
4.4.8 Others Revenue Market Share of LFA-based Cardiac by Company
4.5 Global LFA-based Cardiac Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche LFA-based Cardiac Products Offered
5.1.4 Roche LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.1.5 Roche LFA-based Cardiac Revenue by Product in 2024
5.1.6 Roche LFA-based Cardiac Revenue by Application in 2024
5.1.7 Roche LFA-based Cardiac Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Corporation Information
5.2.2 Abbott Description, Business Overview
5.2.3 Abbott LFA-based Cardiac Products Offered
5.2.4 Abbott LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.2.5 Abbott LFA-based Cardiac Revenue by Product in 2024
5.2.6 Abbott LFA-based Cardiac Revenue by Application in 2024
5.2.7 Abbott LFA-based Cardiac Revenue by Geographic Area in 2024
5.2.8 Abbott Recent Developments
5.3 Siemens
5.3.1 Siemens Corporation Information
5.3.2 Siemens Description, Business Overview
5.3.3 Siemens LFA-based Cardiac Products Offered
5.3.4 Siemens LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.3.5 Siemens LFA-based Cardiac Revenue by Product in 2024
5.3.6 Siemens LFA-based Cardiac Revenue by Application in 2024
5.3.7 Siemens LFA-based Cardiac Revenue by Geographic Area in 2024
5.3.8 Siemens Recent Developments
5.4 Danaher
5.4.1 Danaher Corporation Information
5.4.2 Danaher Description, Business Overview
5.4.3 Danaher LFA-based Cardiac Products Offered
5.4.4 Danaher LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.4.5 Danaher LFA-based Cardiac Revenue by Product in 2024
5.4.6 Danaher LFA-based Cardiac Revenue by Application in 2024
5.4.7 Danaher LFA-based Cardiac Revenue by Geographic Area in 2024
5.4.8 Danaher Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Corporation Information
5.5.2 Bio-Rad Laboratories Description, Business Overview
5.5.3 Bio-Rad Laboratories LFA-based Cardiac Products Offered
5.5.4 Bio-Rad Laboratories LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.5.5 Bio-Rad Laboratories LFA-based Cardiac Revenue by Product in 2024
5.5.6 Bio-Rad Laboratories LFA-based Cardiac Revenue by Application in 2024
5.5.7 Bio-Rad Laboratories LFA-based Cardiac Revenue by Geographic Area in 2024
5.5.8 Bio-Rad Laboratories Recent Developments
5.6 BioMérieux
5.6.1 BioMérieux Corporation Information
5.6.2 BioMérieux Description, Business Overview
5.6.3 BioMérieux LFA-based Cardiac Products Offered
5.6.4 BioMérieux LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.6.5 BioMérieux LFA-based Cardiac Revenue by Product in 2024
5.6.6 BioMérieux LFA-based Cardiac Revenue by Application in 2024
5.6.7 BioMérieux LFA-based Cardiac Revenue by Geographic Area in 2024
5.6.8 BioMérieux Recent Developments
5.7 Thermo Fisher
5.7.1 Thermo Fisher Corporation Information
5.7.2 Thermo Fisher Description, Business Overview
5.7.3 Thermo Fisher LFA-based Cardiac Products Offered
5.7.4 Thermo Fisher LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.7.5 Thermo Fisher LFA-based Cardiac Revenue by Product in 2024
5.7.6 Thermo Fisher LFA-based Cardiac Revenue by Application in 2024
5.7.7 Thermo Fisher LFA-based Cardiac Revenue by Geographic Area in 2024
5.7.8 Thermo Fisher Recent Developments
5.8 Ortho Clinical Diagnostics
5.8.1 Ortho Clinical Diagnostics Corporation Information
5.8.2 Ortho Clinical Diagnostics Description, Business Overview
5.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Products Offered
5.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.8.5 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Product in 2024
5.8.6 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Application in 2024
5.8.7 Ortho Clinical Diagnostics LFA-based Cardiac Revenue by Geographic Area in 2024
5.8.8 Ortho Clinical Diagnostics Recent Developments
5.9 LSI Medience Corporation
5.9.1 LSI Medience Corporation Corporation Information
5.9.2 LSI Medience Corporation Description, Business Overview
5.9.3 LSI Medience Corporation LFA-based Cardiac Products Offered
5.9.4 LSI Medience Corporation LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.9.5 LSI Medience Corporation LFA-based Cardiac Revenue by Product in 2024
5.9.6 LSI Medience Corporation LFA-based Cardiac Revenue by Application in 2024
5.9.7 LSI Medience Corporation LFA-based Cardiac Revenue by Geographic Area in 2024
5.9.8 LSI Medience Corporation Recent Developments
5.10 Randox laboratories
5.10.1 Randox laboratories Corporation Information
5.10.2 Randox laboratories Description, Business Overview
5.10.3 Randox laboratories LFA-based Cardiac Products Offered
5.10.4 Randox laboratories LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.10.5 Randox laboratories LFA-based Cardiac Revenue by Product in 2024
5.10.6 Randox laboratories LFA-based Cardiac Revenue by Application in 2024
5.10.7 Randox laboratories LFA-based Cardiac Revenue by Geographic Area in 2024
5.10.8 Randox laboratories Recent Developments
5.11 Wondfo Biotech
5.11.1 Wondfo Biotech Corporation Information
5.11.2 Wondfo Biotech Description, Business Overview
5.11.3 Wondfo Biotech LFA-based Cardiac Products Offered
5.11.4 Wondfo Biotech LFA-based Cardiac Revenue and Gross Margin (2020-2025)
5.11.5 Wondfo Biotech LFA-based Cardiac Revenue by Product in 2024
5.11.6 Wondfo Biotech LFA-based Cardiac Revenue by Application in 2024
5.11.7 Wondfo Biotech LFA-based Cardiac Revenue by Geographic Area in 2024
5.11.8 Wondfo Biotech Recent Developments
6 North America
6.1 North America LFA-based Cardiac Market Size YoY Growth 2020-2031
6.2 North America LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
6.3 North America LFA-based Cardiac Revenue by Type (2020-2025)
6.4 North America LFA-based Cardiac Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific LFA-based Cardiac Market Size YoY Growth 2020-2031
7.2 Asia-Pacific LFA-based Cardiac Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific LFA-based Cardiac Revenue by Type (2020-2025)
7.4 Asia-Pacific LFA-based Cardiac Revenue by Application (2020-2025)
8 Europe
8.1 Europe LFA-based Cardiac Market Size YoY Growth 2020-2031
8.2 Europe LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
8.3 Europe LFA-based Cardiac Revenue by Type (2020-2025)
8.4 Europe LFA-based Cardiac Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America LFA-based Cardiac Market Size YoY Growth 2020-2031
9.2 Latin America LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
9.3 Latin America LFA-based Cardiac Revenue by Type (2020-2025)
9.4 Latin America LFA-based Cardiac Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America LFA-based Cardiac Market Size YoY Growth 2020-2031
10.2 Middle East and Africa LFA-based Cardiac Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa LFA-based Cardiac Revenue by Type (2020-2025)
10.4 Middle East and Africa LFA-based Cardiac Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 LFA-based Cardiac Supply Chain Analysis
11.2 LFA-based Cardiac Key Raw Materials and Upstream Suppliers
11.3 LFA-based Cardiac Clients Analysis
11.4 LFA-based Cardiac Sales Channel and Sales Model Analysis
11.4.1 LFA-based Cardiac Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 LFA-based Cardiac Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 LFA-based Cardiac Distributors
12 LFA-based Cardiac Market Dynamics
12.1 LFA-based Cardiac Industry Trends
12.2 LFA-based Cardiac Market Drivers
12.3 LFA-based Cardiac Market Challenges
12.4 LFA-based Cardiac Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global LFA-based Cardiac Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global LFA-based Cardiac Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global LFA-based Cardiac Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global LFA-based Cardiac Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global LFA-based Cardiac Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global LFA-based Cardiac Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)
Table 11. LFA-based Cardiac Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top LFA-based Cardiac Players by Revenue (US$ Million) in 2024
Table 13. Global LFA-based Cardiac Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global LFA-based Cardiac by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2024)
Table 15. Global LFA-based Cardiac Companies Headquarters
Table 16. Date of International Companies Enter into LFA-based Cardiac Market
Table 17. Global LFA-based Cardiac Companies Product & Service
Table 18. Global LFA-based Cardiac Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche LFA-based Cardiac Product
Table 22. Roche LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 24. Roche Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 25. Roche Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Abbott Corporation Information
Table 28. Abbott Description and Business Overview
Table 29. Abbott LFA-based Cardiac Product
Table 30. Abbott LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Abbott Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 32. Abbott Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 33. Abbott Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 34. Abbott Recent Developments
Table 35. Siemens Corporation Information
Table 36. Siemens Description and Business Overview
Table 37. Siemens LFA-based Cardiac Product
Table 38. Siemens LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Siemens Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 40. Siemens Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 41. Siemens Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 42. Siemens Recent Developments
Table 43. Danaher Corporation Information
Table 44. Danaher Description and Business Overview
Table 45. Danaher LFA-based Cardiac Product
Table 46. Danaher LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Danaher Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 48. Danaher Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 49. Danaher Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 50. Danaher Recent Developments
Table 51. Bio-Rad Laboratories Corporation Information
Table 52. Bio-Rad Laboratories Description and Business Overview
Table 53. Bio-Rad Laboratories LFA-based Cardiac Product
Table 54. Bio-Rad Laboratories LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 56. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 57. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 58. Bio-Rad Laboratories Recent Developments
Table 59. BioMérieux Corporation Information
Table 60. BioMérieux Description and Business Overview
Table 61. BioMérieux LFA-based Cardiac Product
Table 62. BioMérieux LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. BioMérieux Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 64. BioMérieux Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 65. BioMérieux Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 66. BioMérieux Recent Developments
Table 67. Thermo Fisher Corporation Information
Table 68. Thermo Fisher Description and Business Overview
Table 69. Thermo Fisher LFA-based Cardiac Product
Table 70. Thermo Fisher LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 72. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 73. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 74. Thermo Fisher Recent Developments
Table 75. Ortho Clinical Diagnostics Corporation Information
Table 76. Ortho Clinical Diagnostics Description and Business Overview
Table 77. Ortho Clinical Diagnostics LFA-based Cardiac Product
Table 78. Ortho Clinical Diagnostics LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 80. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 81. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 82. Ortho Clinical Diagnostics Recent Developments
Table 83. LSI Medience Corporation Corporation Information
Table 84. LSI Medience Corporation Description and Business Overview
Table 85. LSI Medience Corporation LFA-based Cardiac Product
Table 86. LSI Medience Corporation LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 88. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 89. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 90. LSI Medience Corporation Recent Developments
Table 91. Randox laboratories Corporation Information
Table 92. Randox laboratories Description and Business Overview
Table 93. Randox laboratories LFA-based Cardiac Product
Table 94. Randox laboratories LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Randox laboratories Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 96. Randox laboratories Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 97. Randox laboratories Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 98. Randox laboratories Recent Developments
Table 99. Wondfo Biotech Corporation Information
Table 100. Wondfo Biotech Description and Business Overview
Table 101. Wondfo Biotech LFA-based Cardiac Product
Table 102. Wondfo Biotech LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 104. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 105. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 106. Wondfo Biotech Recent Developments
Table 107. North America LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific LFA-based Cardiac Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific LFA-based Cardiac Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 127. LFA-based Cardiac Key Raw Materials, Industry Status and Trend
Table 128. LFA-based Cardiac Key Raw Materials and Upstream Suppliers
Table 129. LFA-based Cardiac Clients Status and Trend
Table 130. LFA-based Cardiac Typical Clients
Table 131. LFA-based Cardiac Distributors
Table 132. LFA-based Cardiac Market Trends
Table 133. LFA-based Cardiac Market Drivers
Table 134. LFA-based Cardiac Market Challenges
Table 135. LFA-based Cardiac Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. LFA-based Cardiac Product Picture
Figure 2. Global LFA-based Cardiac Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global LFA-based Cardiac Revenue Market Share by Type in 2024 & 2031
Figure 4. Troponin I Product Picture
Figure 5. Troponin T Product Picture
Figure 6. CK-MB Product Picture
Figure 7. Myoglobin Product Picture
Figure 8. Others Product Picture
Figure 9. Global LFA-based Cardiac Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global LFA-based Cardiac Revenue Market Share by Application in 2024 & 2031
Figure 11. Laboratory Testing
Figure 12. Point-of-care Testing
Figure 13. LFA-based Cardiac Report Years Considered
Figure 14. Global LFA-based Cardiac Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global LFA-based Cardiac Market Size (2020-2031) & (US$ Million)
Figure 16. Global LFA-based Cardiac Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global LFA-based Cardiac Revenue Market Share by Region (2020-2031)
Figure 18. Global LFA-based Cardiac Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global LFA-based Cardiac Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Troponin I of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 21. Troponin T of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 22. CK-MB of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 23. Myoglobin of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 24. Others of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 25. LFA-based Cardiac Revenue Share by Company (2024)
Figure 26. LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Troponin I Revenue Proportion by Company in 2024
Figure 28. Troponin T Revenue Proportion by Company in 2024
Figure 29. CK-MB Revenue Proportion by Company in 2024
Figure 30. Myoglobin Revenue Proportion by Company in 2024
Figure 31. Others Revenue Proportion by Company in 2024
Figure 32. North America LFA-based Cardiac Revenue 2020-2031 (US$ Million)
Figure 33. North America LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 34. North America LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific LFA-based Cardiac Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific LFA-based Cardiac Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 39. Europe LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe LFA-based Cardiac Revenue Market Share by Country (2020-2031)
Figure 41. Europe LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 42. Europe LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 43. Latin America LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America LFA-based Cardiac Revenue Market Share by Country (2020-2031)
Figure 45. Latin America LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 46. Latin America LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa LFA-based Cardiac Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 51. LFA-based Cardiac Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of LFA-based Cardiac Raw Materials by Region in 2024
Figure 53. LFA-based Cardiac Distribution Channels
Figure 54. Global LFA-based Cardiac Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global LFA-based Cardiac Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global LFA-based Cardiac Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global LFA-based Cardiac Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global LFA-based Cardiac Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global LFA-based Cardiac Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global LFA-based Cardiac Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global LFA-based Cardiac Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. LFA-based Cardiac Revenue by Company (2020-2025) & (US$ Million)
Table 11. LFA-based Cardiac Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top LFA-based Cardiac Players by Revenue (US$ Million) in 2024
Table 13. Global LFA-based Cardiac Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global LFA-based Cardiac by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2024)
Table 15. Global LFA-based Cardiac Companies Headquarters
Table 16. Date of International Companies Enter into LFA-based Cardiac Market
Table 17. Global LFA-based Cardiac Companies Product & Service
Table 18. Global LFA-based Cardiac Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche LFA-based Cardiac Product
Table 22. Roche LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 24. Roche Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 25. Roche Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Abbott Corporation Information
Table 28. Abbott Description and Business Overview
Table 29. Abbott LFA-based Cardiac Product
Table 30. Abbott LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Abbott Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 32. Abbott Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 33. Abbott Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 34. Abbott Recent Developments
Table 35. Siemens Corporation Information
Table 36. Siemens Description and Business Overview
Table 37. Siemens LFA-based Cardiac Product
Table 38. Siemens LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Siemens Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 40. Siemens Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 41. Siemens Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 42. Siemens Recent Developments
Table 43. Danaher Corporation Information
Table 44. Danaher Description and Business Overview
Table 45. Danaher LFA-based Cardiac Product
Table 46. Danaher LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Danaher Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 48. Danaher Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 49. Danaher Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 50. Danaher Recent Developments
Table 51. Bio-Rad Laboratories Corporation Information
Table 52. Bio-Rad Laboratories Description and Business Overview
Table 53. Bio-Rad Laboratories LFA-based Cardiac Product
Table 54. Bio-Rad Laboratories LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 56. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 57. Bio-Rad Laboratories Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 58. Bio-Rad Laboratories Recent Developments
Table 59. BioMérieux Corporation Information
Table 60. BioMérieux Description and Business Overview
Table 61. BioMérieux LFA-based Cardiac Product
Table 62. BioMérieux LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. BioMérieux Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 64. BioMérieux Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 65. BioMérieux Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 66. BioMérieux Recent Developments
Table 67. Thermo Fisher Corporation Information
Table 68. Thermo Fisher Description and Business Overview
Table 69. Thermo Fisher LFA-based Cardiac Product
Table 70. Thermo Fisher LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 72. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 73. Thermo Fisher Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 74. Thermo Fisher Recent Developments
Table 75. Ortho Clinical Diagnostics Corporation Information
Table 76. Ortho Clinical Diagnostics Description and Business Overview
Table 77. Ortho Clinical Diagnostics LFA-based Cardiac Product
Table 78. Ortho Clinical Diagnostics LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 80. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 81. Ortho Clinical Diagnostics Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 82. Ortho Clinical Diagnostics Recent Developments
Table 83. LSI Medience Corporation Corporation Information
Table 84. LSI Medience Corporation Description and Business Overview
Table 85. LSI Medience Corporation LFA-based Cardiac Product
Table 86. LSI Medience Corporation LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 88. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 89. LSI Medience Corporation Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 90. LSI Medience Corporation Recent Developments
Table 91. Randox laboratories Corporation Information
Table 92. Randox laboratories Description and Business Overview
Table 93. Randox laboratories LFA-based Cardiac Product
Table 94. Randox laboratories LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Randox laboratories Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 96. Randox laboratories Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 97. Randox laboratories Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 98. Randox laboratories Recent Developments
Table 99. Wondfo Biotech Corporation Information
Table 100. Wondfo Biotech Description and Business Overview
Table 101. Wondfo Biotech LFA-based Cardiac Product
Table 102. Wondfo Biotech LFA-based Cardiac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Product in 2024
Table 104. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Application in 2024
Table 105. Wondfo Biotech Revenue Proportion of LFA-based Cardiac by Geographic Area in 2024
Table 106. Wondfo Biotech Recent Developments
Table 107. North America LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific LFA-based Cardiac Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific LFA-based Cardiac Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa LFA-based Cardiac Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa LFA-based Cardiac Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa LFA-based Cardiac Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa LFA-based Cardiac Revenue by Application (2020-2025) & (US$ Million)
Table 127. LFA-based Cardiac Key Raw Materials, Industry Status and Trend
Table 128. LFA-based Cardiac Key Raw Materials and Upstream Suppliers
Table 129. LFA-based Cardiac Clients Status and Trend
Table 130. LFA-based Cardiac Typical Clients
Table 131. LFA-based Cardiac Distributors
Table 132. LFA-based Cardiac Market Trends
Table 133. LFA-based Cardiac Market Drivers
Table 134. LFA-based Cardiac Market Challenges
Table 135. LFA-based Cardiac Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. LFA-based Cardiac Product Picture
Figure 2. Global LFA-based Cardiac Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global LFA-based Cardiac Revenue Market Share by Type in 2024 & 2031
Figure 4. Troponin I Product Picture
Figure 5. Troponin T Product Picture
Figure 6. CK-MB Product Picture
Figure 7. Myoglobin Product Picture
Figure 8. Others Product Picture
Figure 9. Global LFA-based Cardiac Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global LFA-based Cardiac Revenue Market Share by Application in 2024 & 2031
Figure 11. Laboratory Testing
Figure 12. Point-of-care Testing
Figure 13. LFA-based Cardiac Report Years Considered
Figure 14. Global LFA-based Cardiac Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global LFA-based Cardiac Market Size (2020-2031) & (US$ Million)
Figure 16. Global LFA-based Cardiac Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global LFA-based Cardiac Revenue Market Share by Region (2020-2031)
Figure 18. Global LFA-based Cardiac Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global LFA-based Cardiac Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Troponin I of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 21. Troponin T of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 22. CK-MB of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 23. Myoglobin of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 24. Others of LFA-based Cardiac Revenue Market Share by Application, 2024 VS 2031
Figure 25. LFA-based Cardiac Revenue Share by Company (2024)
Figure 26. LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Troponin I Revenue Proportion by Company in 2024
Figure 28. Troponin T Revenue Proportion by Company in 2024
Figure 29. CK-MB Revenue Proportion by Company in 2024
Figure 30. Myoglobin Revenue Proportion by Company in 2024
Figure 31. Others Revenue Proportion by Company in 2024
Figure 32. North America LFA-based Cardiac Revenue 2020-2031 (US$ Million)
Figure 33. North America LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 34. North America LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific LFA-based Cardiac Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific LFA-based Cardiac Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 39. Europe LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe LFA-based Cardiac Revenue Market Share by Country (2020-2031)
Figure 41. Europe LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 42. Europe LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 43. Latin America LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America LFA-based Cardiac Revenue Market Share by Country (2020-2031)
Figure 45. Latin America LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 46. Latin America LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa LFA-based Cardiac Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa LFA-based Cardiac Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa LFA-based Cardiac Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa LFA-based Cardiac Revenue Market Share by Application (2020-2025)
Figure 51. LFA-based Cardiac Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of LFA-based Cardiac Raw Materials by Region in 2024
Figure 53. LFA-based Cardiac Distribution Channels
Figure 54. Global LFA-based Cardiac Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global LFA-based Cardiac Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232